Basic science under threat: Lessons from the Skirball Institute.
Journal
Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066
Informations de publication
Date de publication:
03 03 2022
03 03 2022
Historique:
received:
26
01
2022
revised:
03
02
2022
accepted:
04
02
2022
entrez:
4
3
2022
pubmed:
5
3
2022
medline:
26
4
2022
Statut:
ppublish
Résumé
Support for basic science has been eclipsed by initiatives aimed at specific medical problems. The latest example is the dismantling of the Skirball Institute at NYU School of Medicine. Here, we reflect on the achievements and mission underlying the Skirball to gain insight into the dividends of maintaining a basic science vision within the academic enterprises.
Identifiants
pubmed: 35245477
pii: S0092-8674(22)00148-9
doi: 10.1016/j.cell.2022.02.008
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
755-758Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests Agnel Sfeir is a co-founder, consultant, and shareholder in Repare Therapeutics. Gord Fishell is a co-founder, consultant, and shareholder in Regel Therapeutics. Alexander Schier, Michael Dustin, Wen-Biao Gan, Alexandra Joyner, Ruth Lehmann, David Ron, David Roth, William S. Talbot, Deborah Yelon, and Arturo Zychlinsky declare no competing interests.